BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 38108075)

  • 1. Research progress on ferroptosis in gliomas (Review).
    Bo Y; Mu L; Yang Z; Li W; Jin M
    Oncol Lett; 2024 Jan; 27(1):36. PubMed ID: 38108075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities.
    Luo Y; Tian G; Fang X; Bai S; Yuan G; Pan Y
    Antioxidants (Basel); 2022 Oct; 11(11):. PubMed ID: 36358495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis in glioma treatment: Current situation, prospects and drug applications.
    Zhou Y; Fang C; Xu H; Yuan L; Liu Y; Wang X; Zhang A; Shao A; Zhou D
    Front Oncol; 2022; 12():989896. PubMed ID: 36249003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment.
    de Souza I; Ramalho MCC; Guedes CB; Osawa IYA; Monteiro LKS; Gomes LR; Rocha CRR
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron Transporters and Ferroptosis in Malignant Brain Tumors.
    Zhao J; Wang Y; Tao L; Chen L
    Front Oncol; 2022; 12():861834. PubMed ID: 35530363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles.
    Yeon Kim S; Tang M; Lu T; Chih SY; Li W
    Brain Res; 2024 May; 1840():149045. PubMed ID: 38821335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFR2 regulates ferroptosis and enhances temozolomide chemo-sensitization in gliomas.
    Tong S; Hong Y; Xu Y; Sun Q; Ye L; Cai J; Ye Z; Chen Q; Tian D
    Exp Cell Res; 2023 Mar; 424(1):113474. PubMed ID: 36702193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment.
    Huang R; Dong R; Wang N; He Y; Zhu P; Wang C; Lan B; Gao Y; Sun L
    Cell Mol Neurobiol; 2022 Oct; 42(7):2055-2074. PubMed ID: 33893939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis sensitization in glioma: exploring the regulatory mechanism of SOAT1 and its therapeutic implications.
    Sun S; Qi G; Chen H; He D; Ma D; Bie Y; Xu L; Feng B; Pang Q; Guo H; Zhang R
    Cell Death Dis; 2023 Nov; 14(11):754. PubMed ID: 37980334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA ATXN8OS promotes ferroptosis and inhibits the temozolomide-resistance of gliomas through the ADAR/GLS2 pathway.
    Luo J; Bai R; Liu Y; Bi H; Shi X; Qu C
    Brain Res Bull; 2022 Aug; 186():27-37. PubMed ID: 35460867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis: A novel therapeutic strategy and mechanism of action in glioma.
    Zhang G; Fang Y; Li X; Zhang Z
    Front Oncol; 2022; 12():947530. PubMed ID: 36185243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
    Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
    Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches targeting ferroptosis in treatment of glioma.
    Zhao J; Zang F; Huo X; Zheng S
    Front Neurol; 2023; 14():1292160. PubMed ID: 38020609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of ferroptosis in brain diseases and ferroptosis-inducing nanomedicine for glioma.
    Wang C; Wen L; Wang K; Wu R; Li M; Zhang Y; Gao Z
    Am J Nucl Med Mol Imaging; 2023; 13(5):179-194. PubMed ID: 38023817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of ferroptosis in glioma.
    Shi J; Yang N; Han M; Qiu C
    Front Oncol; 2022; 12():993316. PubMed ID: 36072803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.
    Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z
    J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ferroptosis in renal cell carcinoma: Potential mechanisms and novel therapeutics.
    Yang L; Fan Y; Zhang Q
    Heliyon; 2023 Aug; 9(8):e18504. PubMed ID: 37554789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in ferroptosis and therapeutic strategies for glioblastoma.
    Lu Q; Lu X; Zhang Y; Huang W; Zhou H; Li T
    Front Mol Biosci; 2022; 9():1068437. PubMed ID: 36710875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
    Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
    Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.